These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 6127353)
41. Edentulousness and neuroleptic-induced neck and trunk dyskinesia. Sandyk R; Kay SR Funct Neurol; 1990; 5(4):361-3. PubMed ID: 1982665 [TBL] [Abstract][Full Text] [Related]
42. Fluphenazine decanoate and tardive dyskinesia. Schiff AA Am J Psychiatry; 1982 Jul; 139(7):969-70. PubMed ID: 6124136 [No Abstract] [Full Text] [Related]
43. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study. Morgenstern H; Glazer WM Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845 [TBL] [Abstract][Full Text] [Related]
44. Prospective study of tardive dyskinesia incidence in the elderly. Saltz BL; Woerner MG; Kane JM; Lieberman JA; Alvir JM; Bergmann KJ; Blank K; Koblenzer J; Kahaner K JAMA; 1991 Nov; 266(17):2402-6. PubMed ID: 1681122 [TBL] [Abstract][Full Text] [Related]
45. Fluphenazine decanoate and tardive dyskinesia: a possible association. Csernansky JG; Grabowski K; Cervantes J; Kaplan J; Yesavage JA Am J Psychiatry; 1981 Oct; 138(10):1362-5. PubMed ID: 7294195 [TBL] [Abstract][Full Text] [Related]
46. Respiratory dyskinesia: review and case reports. Chiang E; Pitts WM; Rodriguez-Garcia M J Clin Psychiatry; 1985 Jun; 46(6):232-4. PubMed ID: 2860099 [TBL] [Abstract][Full Text] [Related]
47. Diurnal variability of orofacial dyskinetic movements. Baca-Garcia E; Stanilla JK; Büchel C; Gattaz WF; de Leon J Pharmacopsychiatry; 1999 Mar; 32(2):73-5. PubMed ID: 10333166 [TBL] [Abstract][Full Text] [Related]
48. Five-year prospective study of clinical EEG, neuropsychological, and demographic risk variables for persistent tardive dyskinesia. Struve FA Adv Biochem Psychopharmacol; 1985; 40():33-6. PubMed ID: 2862766 [No Abstract] [Full Text] [Related]
49. Tardive dyskinesia in schizophrenics under 60 years of age. Kolakowska T; Williams AO; Ardern M; Reveley MA Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762 [TBL] [Abstract][Full Text] [Related]
50. Adolescents on neuroleptic medication: is this population at risk for tardive dyskinesia? McDermid SA; Hood J; Bockus S; D'Alessandro E Can J Psychiatry; 1998 Aug; 43(6):629-31. PubMed ID: 9729692 [TBL] [Abstract][Full Text] [Related]
51. Incidence of tardive dyskinesia in patients receiving depot neuroleptic injection. Gibson AC Acta Psychiatr Scand Suppl; 1981; 291():111-6. PubMed ID: 6113729 [No Abstract] [Full Text] [Related]
53. The reversibility of "permanent" tardive dyskinesia. Klawans HL; Tanner CM; Barr A Clin Neuropharmacol; 1984; 7(2):153-9. PubMed ID: 6145520 [TBL] [Abstract][Full Text] [Related]
54. Pharmacy-based screening program for tardive dyskinesia. Ahrens TN; Sramek JJ; Herrera JM; Jewett CM; Alcorn VE Drug Intell Clin Pharm; 1988 Mar; 22(3):205-8. PubMed ID: 2896586 [TBL] [Abstract][Full Text] [Related]
55. Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Kane JM; Smith JM Arch Gen Psychiatry; 1982 Apr; 39(4):473-81. PubMed ID: 6121548 [TBL] [Abstract][Full Text] [Related]
56. [Evaluation of the incidence of tardive dyskinesias in 3 groups of patients treated with different neuroleptics]. Barcia D; Pozo P; Ruiz ME; Forcadell F; Morcillo L; Soria JM; Carrasco E Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1987; 15(1):25-8. PubMed ID: 3577874 [No Abstract] [Full Text] [Related]
57. Assessment of tardive dyskinesia in psychiatric outpatients using a standardized rating scale. Rey JM; Hunt GE; Johnson GF Aust N Z J Psychiatry; 1981 Mar; 15(1):33-7. PubMed ID: 6973337 [TBL] [Abstract][Full Text] [Related]
58. [Effects and complications of neuroleptics (110 hospitalizations in neurology)]. Destee A; Montagne B; Rousseaux M; Petit H; Warot P Lille Med; 1980; 25(6):291-5. PubMed ID: 6105602 [No Abstract] [Full Text] [Related]
59. An interview with Jeffrey A. Lieberman: Tardive Dyskinesia. [interview by Sussman Norman]. Lieberman JA CNS Spectr; 2007 Oct; 12(10):747-50. PubMed ID: 18018327 [No Abstract] [Full Text] [Related]